# MGAT4A

## Overview
MGAT4A is a gene that encodes the enzyme alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A, a glycosyltransferase involved in the N-glycosylation pathway within the Golgi apparatus. This enzyme is responsible for the formation of β1-4 GlcNAc branches on the α1-3 mannose arm of N-glycans, a process crucial for the proper glycosylation of glycoproteins, which in turn affects their stability, folding, and function (KhoderAgha2019Nacetylglucosaminyltransferases; Nagae2022Discovery). MGAT4A is particularly significant in pancreatic β-cells, where it facilitates the glycosylation of glucose transporter-2 (GLUT2), thereby supporting glucose uptake and insulin secretion (Abdel2014Golgi; Nagae2022Discovery). The enzyme's activity is essential for maintaining glucose homeostasis and is implicated in metabolic regulation, with its dysregulation linked to diabetic phenotypes and cancer progression (Zhang2023GlycosylationRelated; Nagae2022Discovery).

## Structure
The MGAT4A protein, also known as alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A, features a unique molecular structure that includes a lectin domain at its C-terminal region. This lectin domain is crucial for the enzyme's activity, as it regulates the recognition of GlcNAc-containing glycans, which are part of N-glycans (Nagae2022Discovery). The lectin domain shows structural similarity to bacterial GlcNAc-binding lectins and is involved in the selective interaction with product N-glycans having a β1-4 GlcNAc branch (Nagae2022Discovery). 

The enzyme's catalytic domain is connected to the lectin domain by a linker, and it adopts a GT-A fold, which is typical of glycosyltransferases (Nagae2022Discovery). The lectin domain itself is characterized by a β-sandwich fold composed of nine β-strands and three short α-helices, resembling structures found in bacterial lectins such as NagH (Nagae2022Discovery). 

MGAT4A is part of the GT54 family in the CAZy database, and its structure is essential for the efficient modification of glycoproteins (Nagae2022Discovery). The protein is expressed in specific tissues, such as the pancreas, and is linked to physiological processes like glucose uptake and insulin secretion (Nagae2022Discovery).

## Function
MGAT4A encodes an enzyme that plays a critical role in the glycosylation process within the Golgi apparatus, specifically in the formation of β1-4 GlcNAc branches on the α1-3 mannose arm of N-glycans. This branching is essential for the proper glycosylation of glycoproteins, which affects their stability, folding, and function (KhoderAgha2019Nacetylglucosaminyltransferases; Nagae2022Discovery). In healthy human cells, MGAT4A is particularly important for the glycosylation of glucose transporter-2 (GLUT2) in pancreatic β-cells. Proper glycosylation by MGAT4A facilitates the interaction of GLUT2 with galectins, maintaining its presence on the cell surface and thereby supporting glucose uptake and insulin secretion (Abdel2014Golgi; Nagae2022Discovery).

MGAT4A is expressed in various tissues, with notable expression in the pancreas, where it contributes to glucose homeostasis by ensuring the proper function of glucose transporters (LópezOrduña2007The; Abdel2014Golgi). The enzyme's activity is crucial for maintaining normal physiological functions, and its downregulation is associated with diabetic phenotypes, highlighting its role in metabolic regulation (Nagae2022Discovery). MGAT4A's function in glycosylation also impacts cell signaling and immune responses, underscoring its importance in cellular and organismal biology (KhoderAgha2019Nacetylglucosaminyltransferases).

## Clinical Significance
Alterations in the expression of the MGAT4A gene have been linked to several diseases, including diabetes and cancer. In the context of diabetes, MGAT4A plays a crucial role in the regulation of glucose transporter-2 (GLUT2) in pancreatic β-cells. Mice deficient in MGAT4A exhibit diabetic phenotypes such as high body weight, elevated blood glucose, and impaired insulin secretion due to enhanced endocytosis of GLUT2 (Nagae2022Discovery). In humans, reduced MGAT4A mRNA levels have been observed in pancreatic beta cells from diabetes patients, suggesting its involvement in the disease (Nagae2022Discovery). Conversely, in type 2 diabetes (T2D) patients, MGAT4A mRNA levels are significantly increased in white blood cells, indicating a pro-inflammatory state associated with chronic metabolic stress (LópezOrduña2007The).

In cancer, MGAT4A is associated with increased invasiveness of cancer cells by modulating glycoprotein functions, including integrin β1. Its dysregulation has been noted in various cancers, such as pancreatic cancer and hepatocellular carcinoma (HCC), where it promotes tumor progression and affects the immune microenvironment (Ide2006Aberrant; Zhang2023GlycosylationRelated). These findings suggest that MGAT4A is a potential target for therapeutic interventions in both diabetes and cancer.

## Interactions
MGAT4A, a glycosyltransferase involved in the N-glycosylation pathway, participates in various interactions within the Golgi apparatus. It is part of a complex network of enzymes and transporters that facilitate the synthesis of complex N-glycans. Although specific interactions involving MGAT4A are not detailed, it is mentioned as part of the glycosylation process involving multi-enzyme/multi-transporter complexes. These complexes include other MGAT family members and nucleotide sugar transporters, which are crucial for efficient glycan branching and processing (KhoderAgha2019Nacetylglucosaminyltransferases).

MGAT4A is also involved in the regulation of glucose transporter-2 (GLUT2) in pancreatic β-cells. This interaction is significant for maintaining glucose homeostasis, as the modification of GLUT2 N-glycans by MGAT4A affects its interaction with galectins, influencing its cell surface residency and function (Nagae2022Discovery). The absence of MGAT4A leads to enhanced endocytosis of GLUT2, which is crucial for glucose uptake and insulin secretion, highlighting its role in glucose metabolism and its potential as a drug target for diabetes (Abdel2014Golgi).


## References


1. (Zhang2023GlycosylationRelated) Glycosylation-Related Genes predict prognosis in Hepatocellular carcinoma. This article has 0 citations.

[2. (Ide2006Aberrant) Yoshihito Ide, Eiji Miyoshi, Tsutomu Nakagawa, Jianguo Gu, Masahiro Tanemura, Toshiro Nishida, Toshinori Ito, Harumi Yamamoto, Yasunori Kozutsumi, and Naoyuki Taniguchi. Aberrant expression of n-acetylglucosaminyltransferase-iva and ivb (gnt-iva and b) in pancreatic cancer. Biochemical and Biophysical Research Communications, 341(2):478–482, March 2006. URL: http://dx.doi.org/10.1016/j.bbrc.2005.12.208, doi:10.1016/j.bbrc.2005.12.208. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2005.12.208)

[3. (KhoderAgha2019Nacetylglucosaminyltransferases) Fawzi Khoder-Agha, Paulina Sosicka, Maria Escriva Conde, Antti Hassinen, Tuomo Glumoff, Mariusz Olczak, and Sakari Kellokumpu. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme–multi-transporter assemblies in golgi membranes in vivo. Cellular and Molecular Life Sciences, 76(9):1821–1832, February 2019. URL: http://dx.doi.org/10.1007/s00018-019-03032-5, doi:10.1007/s00018-019-03032-5. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03032-5)

[4. (Abdel2014Golgi) Anas M Abdel Rahman, Michael Ryczko, Miyako Nakano, Judy Pawling, Tania Rodrigues, Anita Johswich, Naoyuki Taniguchi, and James W Dennis. Golgi n-glycan branching n-acetylglucosaminyltransferases i, v and vi promote nutrient uptake and metabolism. Glycobiology, 25(2):225–240, October 2014. URL: http://dx.doi.org/10.1093/glycob/cwu105, doi:10.1093/glycob/cwu105. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/cwu105)

[5. (LópezOrduña2007The) Eduardo López-Orduña, Miguel Cruz, and Jaime García-Mena. The transcription of mgat4a glycosyl transferase is increased in white cells of peripheral blood of type 2 diabetes patients. BMC Genetics, October 2007. URL: http://dx.doi.org/10.1186/1471-2156-8-73, doi:10.1186/1471-2156-8-73. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2156-8-73)

[6. (Nagae2022Discovery) Masamichi Nagae, Tetsuya Hirata, Hiroaki Tateno, Sushil K. Mishra, Noriyoshi Manabe, Naoko Osada, Yuko Tokoro, Yoshiki Yamaguchi, Robert J. Doerksen, Toshiyuki Shimizu, and Yasuhiko Kizuka. Discovery of a lectin domain that regulates enzyme activity in mouse n-acetylglucosaminyltransferase-iva (mgat4a). Communications Biology, July 2022. URL: http://dx.doi.org/10.1038/s42003-022-03661-w, doi:10.1038/s42003-022-03661-w. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-022-03661-w)